Chemo-immunotherapy outcomes of KRAS-G12C mutant lung cancer compared to other molecular subtypes of KRAS-mutant lung cancer Meeting Abstract


Authors: Arbour, K. C.; Ricciuti, B.; Rizvi, H.; Hellmann, M. D.; Yu, H. A.; Ladanyi, M.; Kris, M. G.; Arcila, M. E.; Rudin, C. M.; Lito, P.; Awad, M. M.; Riely, G. J.
Abstract Title: Chemo-immunotherapy outcomes of KRAS-G12C mutant lung cancer compared to other molecular subtypes of KRAS-mutant lung cancer
Meeting Title: 2021 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 39
Issue: 15 Suppl.
Meeting Dates: 2021 Jun 4-8
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2021-05-20
Language: English
ACCESSION: WOS:000708120605067
DOI: 10.1200/JCO.2021.39.15_suppl.9088
PROVIDER: wos
Notes: Meeting Abstract: 9088 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Helena Alexandra Yu
    281 Yu
  2. Piro Lito
    58 Lito
  3. Marc Ladanyi
    1328 Ladanyi
  4. Gregory J Riely
    599 Riely
  5. Maria Eugenia Arcila
    660 Arcila
  6. Mark Kris
    869 Kris
  7. Matthew David Hellmann
    412 Hellmann
  8. Charles Rudin
    489 Rudin
  9. Kathryn Cecilia Arbour
    88 Arbour
  10. Hira Abbas Rizvi
    123 Rizvi